Polymeric nanoparticles encapsulating novel TLR7/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy

Biomaterials
Hyunjoon KimJayanth Panyam

Abstract

Cytotoxic T lymphocytes (CTLs) play a major role in cancer immunotherapy because of their ability to directly kill tumor cells and secrete tumor suppressive cytokines. Anticancer vaccines aim to provoke tumor-specific CTL responses, which require activation of antigen presenting cells (APCs) including dendritic cells (DCs) and macrophages. Therefore, a potent immunostimulatory adjuvant capable of activating APCs is an essential component of anticancer vaccines. In this study, we introduce novel TLR 7/8 bi-specific agonists that significantly enhance cytokine secretion compared to TLR7 mono-selective compounds. Encapsulation of these TLR 7/8 agonists in poly(lactide-co-glycolide) (PLGA) nanoparticles increased the co-stimulatory molecule expression and antigen presentation via MHC I by DCs compared to the soluble agonist. When administered subcutaneously, these nanoparticles migrated to draining lymph node and triggered DC activation and expansion. This lead to expansion of antigen-specific CD8 T cells and enhanced CTL response, which resulted in significant prophylactic and therapeutic efficacy in melanoma, bladder and renal cell carcinoma tumor models. Importantly, our studies demonstrate significant reductions in systemic met...Continue Reading

Citations

Jan 11, 2019·Journal of Functional Biomaterials·Eleonora CalzoniCarla Emiliani
Jan 23, 2019·Advanced Healthcare Materials·Eun Sook LeeJae Hyung Park
Oct 1, 2019·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Yuhao HaoYuanzeng Min
Oct 1, 2019·Advanced Materials·Pengcheng ZhangYaping Li
Sep 15, 2020·Pediatric Research·Dheeraj SoniDavid J Dowling
Apr 3, 2019·Advanced Science·Yu MiAndrew Z Wang
Sep 12, 2019·Advanced Science·Xiangru FengXuesi Chen
Mar 4, 2020·Acta Pharmacologica Sinica·Fan YangZhi-Yong Qian
May 18, 2020·Cellular & Molecular Immunology·Sadiq UmarShiva Shahrara
Aug 28, 2020·Frontiers in Chemistry·Hong-Guo Hu, Yan-Mei Li
Jan 6, 2019·The Journal of Pharmacology and Experimental Therapeutics·Hyunjoon KimJayanth Panyam
Mar 27, 2020·Immunotherapy·Vidhi KhannaThomas S Griffith
Jan 21, 2020·Archives of Pharmacal Research·Md AsadujjamanJun-Pil Jee
Feb 2, 2019·Current Medicinal Chemistry·Mário FernandesAndreia C Gomes
Aug 28, 2020·Frontiers in Bioengineering and Biotechnology·Junqing WangJinjun Shi
Dec 14, 2018·Oncoimmunology·Melody SmithLorenzo Galluzzi
Nov 27, 2019·Current Topics in Medicinal Chemistry·David C McGowan
Aug 29, 2019·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Alice ComberlatoMaartje M C Bastings
Oct 14, 2020·Biomaterials Science·Oluwaseyi T Shofolawe-BakareThomas A Werfel
Oct 27, 2020·International Journal of Cancer. Journal International Du Cancer·Edyta Wieczorek, Malgorzata A Garstka
Dec 15, 2020·Expert Review of Vaccines·Mohammad Zaki AhmadSohail Akhter
Jan 16, 2021·Drug Discovery Today·Sandeep KumarAjay Rana
Oct 13, 2019·Seminars in Immunology·Jean-Philippe BastienDenis Claude Roy
Nov 17, 2020·International Journal of Nanomedicine·Alicja KarabaszKrzysztof Szczepanowicz
Jan 8, 2021·Frontiers in Chemistry·Neelam ThakurParames C Sil
Nov 16, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hua ZhangKatherine W Ferrara
Feb 27, 2021·Clinical and Translational Medicine·Minghai ZhangYu Wang
Jul 23, 2019·Advanced Drug Delivery Reviews·Joseph M CasterAndrew Z Wang
May 23, 2021·Advanced Healthcare Materials·Hang WuGuangxi Zhai
May 30, 2021·Advanced Materials·DaeYong LeeBetty Y S Kim
Aug 8, 2021·International Journal of Molecular Sciences·Akshita ChauhanAbdelwahab Omri
Sep 12, 2020·Chemical Reviews·Wen-Hao Li, Yan-Mei Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.